{"id":"https://openalex.org/W7204079384","doi":"https://doi.org/10.1158/2767-9764.crc-25-0799","title":"CRB-701: A Second-generation Nectin-4\u2013Targeted Antibody\u2013Drug Conjugate with Optimized Stability and Pharmacokinetics for the Treatment of Solid Tumors","display_name":"CRB-701: A Second-generation Nectin-4\u2013Targeted Antibody\u2013Drug Conjugate with Optimized Stability and Pharmacokinetics for the Treatment of Solid Tumors","publication_year":2026,"publication_date":"2026-08-24","ids":{"openalex":"https://openalex.org/W7204079384","doi":"https://doi.org/10.1158/2767-9764.crc-25-0799","pmid":"https://pubmed.ncbi.nlm.nih.gov/42636059","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13576400"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.crc-25-0799","doi":"https://doi.org/10.1158/2767-9764.crc-25-0799","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.crc-25-0799","pdf_url":null,"source":{"id":"https://openalex.org/S4210217028","display_name":"Cancer Research Communications","issn_l":"2767-9764","issn":["2767-9764"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research Communications","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2767-9764.crc-25-0799","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5147966218","display_name":"Zhaopeng Sun","orcid":"https://orcid.org/0009-0008-1972-8567","observed_orcids":["https://orcid.org/0009-0008-1972-8567"]},"institutions":[{"id":"https://openalex.org/I4387153926","display_name":"CSPC Pharmaceutical Group","ror":"https://ror.org/016mq8947","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387153926"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhaopeng Sun","raw_affiliation_strings":["1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China"],"raw_orcid":"https://orcid.org/0009-0008-1972-8567","affiliations":[{"raw_affiliation_string":"1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China","institution_ids":["https://openalex.org/I4387153926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151818693","display_name":"Mo Dan","orcid":"https://orcid.org/0000-0003-0601-5345","observed_orcids":["https://orcid.org/0000-0003-0601-5345"]},"institutions":[{"id":"https://openalex.org/I4387153926","display_name":"CSPC Pharmaceutical Group","ror":"https://ror.org/016mq8947","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387153926"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Mo Dan","raw_affiliation_strings":["1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China"],"raw_orcid":"https://orcid.org/0000-0003-0601-5345","affiliations":[{"raw_affiliation_string":"1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China","institution_ids":["https://openalex.org/I4387153926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151807882","display_name":"Lu Lv","orcid":"https://orcid.org/0009-0004-1560-8008","observed_orcids":["https://orcid.org/0009-0004-1560-8008"]},"institutions":[{"id":"https://openalex.org/I4387153926","display_name":"CSPC Pharmaceutical Group","ror":"https://ror.org/016mq8947","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387153926"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lu Lv","raw_affiliation_strings":["1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China"],"raw_orcid":"https://orcid.org/0009-0004-1560-8008","affiliations":[{"raw_affiliation_string":"1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China","institution_ids":["https://openalex.org/I4387153926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147941989","display_name":"Mingyue Shen","orcid":"https://orcid.org/0009-0000-8760-2079","observed_orcids":["https://orcid.org/0009-0000-8760-2079"]},"institutions":[{"id":"https://openalex.org/I4387153926","display_name":"CSPC Pharmaceutical Group","ror":"https://ror.org/016mq8947","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387153926"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Mingyue Shen","raw_affiliation_strings":["1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China"],"raw_orcid":"https://orcid.org/0009-0000-8760-2079","affiliations":[{"raw_affiliation_string":"1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China","institution_ids":["https://openalex.org/I4387153926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147983795","display_name":"Can Yuan","orcid":"https://orcid.org/0009-0004-6588-9573","observed_orcids":["https://orcid.org/0009-0004-6588-9573"]},"institutions":[{"id":"https://openalex.org/I4387153926","display_name":"CSPC Pharmaceutical Group","ror":"https://ror.org/016mq8947","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387153926"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Can Yuan","raw_affiliation_strings":["1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China"],"raw_orcid":"https://orcid.org/0009-0004-6588-9573","affiliations":[{"raw_affiliation_string":"1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China","institution_ids":["https://openalex.org/I4387153926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103118952","display_name":"Congcong Niu","orcid":"https://orcid.org/0009-0006-6189-7079","observed_orcids":["https://orcid.org/0009-0006-6189-7079","https://orcid.org/0000-0003-4388-1402"]},"institutions":[{"id":"https://openalex.org/I4387153926","display_name":"CSPC Pharmaceutical Group","ror":"https://ror.org/016mq8947","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387153926"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Congcong Niu","raw_affiliation_strings":["1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China"],"raw_orcid":"https://orcid.org/0009-0006-6189-7079","affiliations":[{"raw_affiliation_string":"1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China","institution_ids":["https://openalex.org/I4387153926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100354630","display_name":"Yang Zhang","orcid":"https://orcid.org/0000-0002-0789-4938","observed_orcids":["https://orcid.org/0000-0002-0789-4938","https://orcid.org/0009-0002-8341-119X","https://orcid.org/0009-0001-6556-3053"]},"institutions":[{"id":"https://openalex.org/I4387153926","display_name":"CSPC Pharmaceutical Group","ror":"https://ror.org/016mq8947","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387153926"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yang Zhang","raw_affiliation_strings":["1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China"],"raw_orcid":"https://orcid.org/0009-0001-6556-3053","affiliations":[{"raw_affiliation_string":"1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China","institution_ids":["https://openalex.org/I4387153926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147970157","display_name":"Xixin Hu","orcid":"https://orcid.org/0009-0000-0868-4812","observed_orcids":["https://orcid.org/0009-0000-0868-4812"]},"institutions":[{"id":"https://openalex.org/I4387153926","display_name":"CSPC Pharmaceutical Group","ror":"https://ror.org/016mq8947","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387153926"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xixin Hu","raw_affiliation_strings":["1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China"],"raw_orcid":"https://orcid.org/0009-0000-0868-4812","affiliations":[{"raw_affiliation_string":"1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China","institution_ids":["https://openalex.org/I4387153926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147911099","display_name":"Xiwu Hui","orcid":"https://orcid.org/0009-0001-8913-2194","observed_orcids":["https://orcid.org/0009-0001-8913-2194"]},"institutions":[{"id":"https://openalex.org/I4387153926","display_name":"CSPC Pharmaceutical Group","ror":"https://ror.org/016mq8947","country_code":"CN","type":"company","lineage":["https://openalex.org/I4387153926"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiwu Hui","raw_affiliation_strings":["1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China"],"raw_orcid":"https://orcid.org/0009-0001-8913-2194","affiliations":[{"raw_affiliation_string":"1CSPC Megalith Biopharmaceutical Co., Ltd., Shijiazhuang, China","institution_ids":["https://openalex.org/I4387153926"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005893416","display_name":"Andrew F. Kolodziej","orcid":"https://orcid.org/0009-0006-5928-4572","observed_orcids":["https://orcid.org/0009-0006-5928-4572"]},"institutions":[{"id":"https://openalex.org/I4210116507","display_name":"Corbus Pharmaceuticals (United States)","ror":"https://ror.org/02advfp87","country_code":"US","type":"company","lineage":["https://openalex.org/I4210116507"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andrew Kolodziej","raw_affiliation_strings":["2Corbus Pharmaceuticals Inc., Norwood, Massachusetts"],"raw_orcid":"https://orcid.org/0009-0006-5928-4572","affiliations":[{"raw_affiliation_string":"2Corbus Pharmaceuticals Inc., Norwood, Massachusetts","institution_ids":["https://openalex.org/I4210116507"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5005893416"],"corresponding_institution_ids":["https://openalex.org/I4210116507"],"apc_list":{"value":2550,"currency":"USD","value_usd":2550},"apc_paid":{"value":2550,"currency":"USD","value_usd":2550},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"9","first_page":"2164","last_page":"2176"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.926800012588501,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.926800012588501,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.01860000006854534,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.013700000010430813,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nectin-4","display_name":"nectin-4","score":0.9710000157356262},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9070000052452087},{"id":"https://openalex.org/keywords/enfortumab-vedotin","display_name":"enfortumab vedotin","score":0.9160000085830688},{"id":"https://openalex.org/keywords/monomethyl-auristatin-e","display_name":"monomethyl auristatin E","score":0.9589999914169312},{"id":"https://openalex.org/keywords/cleavable-linkers","display_name":"cleavable linkers","score":0.8920000195503235},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8429999947547913},{"id":"https://openalex.org/keywords/plasma-stability","display_name":"plasma stability","score":0.656000018119812},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.7699999809265137},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.7149999737739563},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9309999942779541},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9919999837875366},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.7509999871253967},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7009999752044678}],"concepts":[{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.7077999711036682},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6883000135421753},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6656000018119812},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5753999948501587},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.54339998960495},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5322999954223633},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5254999995231628},{"id":"https://openalex.org/C2780557392","wikidata":"https://www.wikidata.org/wiki/Q523796","display_name":"Linker","level":2,"score":0.5145000219345093},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.49900001287460327},{"id":"https://openalex.org/C139770010","wikidata":"https://www.wikidata.org/wiki/Q1339807","display_name":"Internalization","level":3,"score":0.44929999113082886},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4456000030040741},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.43970000743865967},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.42750000953674316},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4027000069618225},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.38659998774528503},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3833000063896179},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.367000013589859},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3490000069141388},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.34549999237060547},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.31630000472068787},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.3089999854564667},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3043999969959259},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.29980000853538513},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.2955999970436096},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.29510000348091125},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.29339998960494995},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2897000014781952},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.28029999136924744},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.2773999869823456},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.27140000462532043},{"id":"https://openalex.org/C2994372470","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell lines","level":4,"score":0.2703999876976013},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.25540000200271606}],"mesh":[{"descriptor_ui":"D000075983","descriptor_name":"Nectins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000075983","descriptor_name":"Nectins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000075983","descriptor_name":"Nectins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015815","descriptor_name":"Cell Adhesion Molecules","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/2767-9764.crc-25-0799","doi":"https://doi.org/10.1158/2767-9764.crc-25-0799","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.crc-25-0799","pdf_url":null,"source":{"id":"https://openalex.org/S4210217028","display_name":"Cancer Research Communications","issn_l":"2767-9764","issn":["2767-9764"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research Communications","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13576400","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13576400/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13576400/pdf/crc-25-0799.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Res Commun","raw_type":"Text"},{"id":"pmid:42636059","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42636059","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research communications","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.crc-25-0799","doi":"https://doi.org/10.1158/2767-9764.crc-25-0799","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.crc-25-0799","pdf_url":null,"source":{"id":"https://openalex.org/S4210217028","display_name":"Cancer Research Communications","issn_l":"2767-9764","issn":["2767-9764"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research Communications","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204079384.pdf","grobid_xml":"https://content.openalex.org/works/W7204079384.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1524815067","https://openalex.org/W2010363872","https://openalex.org/W2066877940","https://openalex.org/W2090057677","https://openalex.org/W2148060514","https://openalex.org/W2155459902","https://openalex.org/W2302699227","https://openalex.org/W2323748784","https://openalex.org/W2531611585","https://openalex.org/W2563990297","https://openalex.org/W2761653596","https://openalex.org/W2940787029","https://openalex.org/W3004668339","https://openalex.org/W3011304206","https://openalex.org/W3112886473","https://openalex.org/W3128485166","https://openalex.org/W3154950152","https://openalex.org/W3166074522","https://openalex.org/W3207489055","https://openalex.org/W4296078948","https://openalex.org/W4306944642","https://openalex.org/W4376958886","https://openalex.org/W4389227511","https://openalex.org/W4392498919","https://openalex.org/W4393115738","https://openalex.org/W4400930831","https://openalex.org/W4401065237","https://openalex.org/W4401326701","https://openalex.org/W4407700164","https://openalex.org/W4408559440","https://openalex.org/W4409117425","https://openalex.org/W4409527847","https://openalex.org/W4410007645","https://openalex.org/W4415941074"],"related_works":["https://openalex.org/W4389227511","https://openalex.org/W4393075181","https://openalex.org/W4376958886","https://openalex.org/W4400520124","https://openalex.org/W7156002619","https://openalex.org/W4407700164","https://openalex.org/W4393085342","https://openalex.org/W4415940743","https://openalex.org/W3165348747","https://openalex.org/W4403685726"],"abstract_inverted_index":{"The":[0],"adhesion":[1],"protein":[2],"nectin-4":[3,149],"is":[4,11,35,238],"a":[5,23,54,80,84,184,198,209,239,270],"clinically":[6],"validated":[7],"tumor-selective":[8],"antigen":[9],"that":[10,194],"overexpressed":[12],"across":[13,143],"multiple":[14],"cancer":[15,116],"types":[16],"and":[17,50,101,109,126,162,181,214,221,253],"has":[18],"been":[19],"successfully":[20],"exploited":[21],"as":[22,61],"target":[24],"for":[25,37,202,228,273],"antibody-drug":[26],"conjugates":[27],"(ADCs),":[28],"most":[29],"notably":[30],"enfortumab":[31],"vedotin":[32],"(EV),":[33],"which":[34],"approved":[36,233,265],"the":[38,48,203,230,263],"treatment":[39,204,274],"of":[40,53,74,114,148,155,205,275],"urothelial":[41],"carcinoma.":[42],"In":[43],"this":[44],"study,":[45],"we":[46],"report":[47],"design":[49],"preclinical":[51],"characterization":[52],"second-generation":[55],"nectin-4-targeted":[56,240,266],"ADC,":[57],"CRB-701":[58,63,91,151,195,237,242,268],"(also":[59],"identified":[60],"SYS6002).":[62],"was":[64,163,254],"synthesized":[65],"using":[66],"microbial":[67],"transglutaminase":[68],"technology":[69],"to":[70,83,138],"conjugate":[71],"two":[72],"molecules":[73],"monomethyl":[75],"auristatin":[76],"E":[77],"(MMAE)":[78],"via":[79],"cleavable":[81],"linker":[82],"highly":[85],"selective,":[86],"high-affinity":[87],"anti-nectin-4":[88],"monoclonal":[89],"antibody.":[90],"exhibited":[92],"potent":[93],"in":[94,97,102,106,159,167,189,251],"vitro":[95],"cytotoxicity":[96],"nectin-4-expressing":[98,206,276],"cell":[99,107],"lines":[100],"vivo":[103],"antitumor":[104,247],"activity":[105],"line-derived":[108,118],"patient-derived":[110,130],"murine":[111],"xenograft":[112],"models":[113],"human":[115],"(cell":[117],"models:":[119],"PC-3-NECTIN4":[120],"prostate":[121],"cancer,":[122,125],"MDA-MB-468":[123],"breast":[124],"HT1376":[127],"bladder":[128,133],"cancer;":[129],"model:":[131],"BL0597":[132],"cancer),":[134],"exhibiting":[135],"efficacy":[136],"similar":[137,244],"or":[139,245],"greater":[140],"than":[141,169,225,261],"EV":[142],"tumors":[144],"with":[145,171,218,256],"varying":[146],"levels":[147,154],"expression.":[150],"delivered":[152],"high":[153],"MMAE":[156,174,259],"upon":[157],"internalization":[158],"tumor":[160],"cells":[161],"markedly":[164],"more":[165,210],"stable":[166],"circulation":[168],"EV,":[170,229,262],"lower":[172,257],"systemic":[173,258],"release,":[175],"an":[176],"approximately":[177],"twofold":[178,185],"longer":[179],"half-life,":[180],"at":[182],"least":[183],"higher":[186,219],"safety":[187],"margin":[188],"monkeys.":[190],"These":[191],"results":[192],"suggest":[193],"may":[196],"be":[197],"promising":[199,271],"alternative":[200,272],"therapeutic":[201,212],"tumors,":[207],"providing":[208],"favorable":[211],"window":[213],"potentially":[215],"enabling":[216],"regimens":[217],"doses":[220],"less":[222],"frequent":[223],"dosing":[224],"those":[226],"required":[227],"only":[231,264],"currently":[232],"nectin-4-targeting":[234],"ADC.":[235,241,267],"SIGNIFICANCE:":[236],"showed":[243],"superior":[246],"activity,":[248],"better":[249],"stability":[250],"plasma,":[252],"associated":[255],"release":[260],"offers":[269],"tumors.":[277]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-25T00:00:00"}